Page 3 - Advanced Accelerator Applications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ARTBIO Raises Oversubscribed and Upsized $90 Million Series A Financing to Progress Pipeline and Isotope Technology Development for New Class of Alpha Radioligand Therapies

ARTBIO Raises Oversubscribed and Upsized $90 Million Series A Financing to Progress Pipeline and Isotope Technology Development for New Class of Alpha Radioligand Therapies
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomEmanuele ostuniDaniel rossettoPhilippe dasseStefan klotterUniversity of osloPrnewswire artbio incBiotechnology innovation organizationThird rock venturesF prime capitalOmega fundsChief technical officerSenior vice presidentSupply chainBringing philippe

Radiopharma startup Artbio raises $90M in sign of field s momentum

BioPharma

Philippe dasseDaniel rossettoEmanuele ostuniEli lillyDive briefRock venturesF prime capitalAdvanced accelerator applicationsMariana oncologyNucleus radiopharma

Newcleo CEO sells Europe on next-gen nuclear energy

Novartis bought Stefano Buono's first startup for $3.9 billion. Now his new generation of nuclear energy is making inroads in Italy and France.

United statesPeter vanhamSergio ermottiPeter thielStefano buonoChloe taylorBryan hoggUrs rohnerNational health serviceCredit suisseDoes europeFilmmaker oliver stoneAdvanced accelerator applicationsWall street

Rare NRG1 Fusion Market to Register Tremendous Growth at a

The dynamics of the rare NRG1 fusion market are anticipated to change in the coming years owing to the improvement in the research and development.

New yorkUnited statesUnited kingdomBio pharmaZenocutuzumab zenoChipscreen biosciencesAfatinib gilotrifAscentage pharmaSalubris biotherapeuticsBristol myers squibbLinton pharmInnovent biologicsChong kun dangEli lillyBridgebio pharmaPierre fabre

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to Y-mAbs Therapeutics Third Quarter 2023 Earnings Conference Call. Please note that today’s event is being recorded.

United statesCharles zhuCourtney duganBo kruseMichael rossiAlec stranahanSteen lisbySue smithMemorial sloan kettering cancer centerMassachusetts institute of technologyBeat childhood cancer research consortiumGe healthcareY mabs therapeutics incY mabs therapeuticsCall transcript novemberY mabs therapeutics third quarter